Christian Brühlmann
Corporate Officer/Principal en ONCONETIX, INC. .
Fortuna: 48 622 $ al 31/05/2024
Cargos activos de Christian Brühlmann
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ONCONETIX, INC. | Corporate Officer/Principal | 01/12/2023 | - |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Fundador | 01/01/2010 | - |
| Corporate Officer/Principal | 01/11/2018 | - | |
| Director/Miembro de la Junta | 01/01/2010 | 01/11/2018 | |
| Director de Operaciones | 01/01/2010 | 01/11/2018 | |
| Director Financiero/CFO | 01/01/2010 | 01/11/2018 |
Historial de carrera de Christian Brühlmann
Formación de Christian Brühlmann.
| University of Zurich | Masters Business Admin |
Estadísticas
Internacional
| Suiza | 3 |
| Estados Unidos | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Christian Brühlmann
- Experiencia
